Xconomy | Seattle - Business + Technology in the Exponential Economy

Biotech, cancer, Life Sciences

Biotech Exec Sentenced to Probation

Luke Timmerman 5/8/09

Christopher Ma, a former director of business affairs with Auburn, WA-based Syntrix Biochip, was sentenced today in U.S. District Court in Seattle to three years of supervised release, 240 hours of community service, and a $5,000 fine for making false statements. Ma, 35, was accused of submitting false audits to the National Institutes of Health, which provided $7.5 million in grants to the company over seven years for cancer research, according to a statement from the U.S. Attorney’s Office in the Western District of Washington.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments (1) | Reprints | Share:

Links to This Post

The Medical Quack: Biotech Exec Sentenced to Probation in Washington – Submitted False Audits to the NIH
5/10/09 12:25 am

[...] Biotech Exec Sentenced to Probation | Xconomy Technorati Tags: NIH,Biotech,Legal case,healthcare,Syntrix Sphere: Related Content addthis_url=’http://ducknetweb.blogspot.com/2009/05/biotech-exec-sentenced-to-probation-in.html’; addthis_title=’Biotech Exec Sentenced to Probation in Washington – Submitted False Audits to the NIH’; addthis_pub=’medicalquack’; Share on FriendFeed Posted by The Medical Quack at 9:08 PM 0 comments Links Labels: Medically Related, Technology [...]